AI for diagnosing and predicting hypertrophic cardiomyopathy
Part of Heart & circulation clinical trials.
This trial uses artificial intelligence to help diagnose and predict outcomes for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes thickened. It may help doctors better understand your condition and plan your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with hypertrophic cardiomyopathy (thickened heart muscle) or have a heart wall thickness of 13 mm or more on an ultrasound.
- You are a healthy adult with no history of heart disease and no signs of thickened heart muscle (if you are in the healthy control group).
- You have a readable electrocardiogram (ECG) recording.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how hypertrophic cardiomyopathy (HCM) affects people in China in real-world settings. It may help doctors understand the condition better and improve care for patients like you.
This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.
This study uses artificial intelligence (AI) to look at heart CT scans (coronary CT angiograms) to help spot different types of cardiomyopathy (diseases of the heart muscle) earlier and more accurately. If you have a cardiomyopathy and have had a heart CT scan before any surgery or device placement, this study may help improve diagnosis and treatment planning.
This study follows people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens, to learn more about how it affects them in real life. It may help doctors better understand and manage the condition.
This study uses a single, advanced heart MRI to get a complete picture of hypertrophic cardiomyopathy—a condition where the heart muscle is thickened. It aims to make diagnosis and treatment planning faster and easier for patients.
This trial tests whether large language models (a type of AI that understands human language) can help cardiologists give better care. If you are a qualified cardiologist who currently treats patients, you may be eligible.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.